The antiviral drug molnupiravir (Lagevrio) slashed the risk of death from COVID-19 in half when given early to older adults. It also lowered all-cause deaths among older adults in the Czech Republic ...

In an interview with The American Journal of Managed Care ® (AJMC ®) at the American Thoracic Society International ...

Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to new UCLA-led research. “Since the strongest predictor of severe COVID-19 is ...

A large-scale study of older adults found that severe COVID-19 infections requiring hospitalizations are associated with accelerated cognitive decline. Milder cases that do not require hospital care ...

COPD may not make it more likely that you contract COVID-19, but it may increase your risk of severe symptoms and hospitalization. Follow these tips to keep yourself safe and healthy. Chronic ...

The drug showed promising results in an international study involving nearly 2,400 participants, and the U.S. Food and Drug Administration is expected to make an approval decision for it in June ...

Learn the latest CDC COVID vaccine recommendations for 2025. Find out why updated shots matter for adults 65+, their safety, timing, and how they reduce severe illness and long COVID. On Sept. 19, ...

Older adults are much more likely to become seriously ill from flu or COVID because aging lung cells can drive excessive immune responses, according to a new study led by researchers at UC San ...